Caption Management’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-115,686	Closed	-$13.2M	–	1541
2024 Q4	$9.79M	Buy	115,686 +105,686	+1,057%	+$9.72M	0.4%	205
2024 Q3	$899K	Buy	+10,000	New	+$873K	0.1%	805
2024 Q1	–	Sell	-17,600	Closed	-$1.48M	–	1235
2023 Q4	$1.4M	Buy	+17,600	New	+$1.18M	0.15%	721
2023 Q1	–	Sell	-4,600	Closed	-$302K	–	1134
2022 Q4	$355K	Buy	+4,600	New	+$275K	0.06%	981
2022 Q2	–	Sell	-157,500	Closed	-$4.98M	–	1480
2022 Q1	$6.52M	Buy	157,500 +117,500	+294%	+$3.64M	0.43%	344
2021 Q4	$1.51M	Sell	40,000 -29,000	-42%	-$1.07M	0.09%	890
2021 Q3	$2.27M	Buy	+69,000	New	+$2.69M	0.15%	716
2020 Q2	–	Sell	-25,000	Closed	-$1.47M	–	948
2020 Q1	$1.47M	Sell	25,000 -63,400	-72%	-$5.17M	0.48%	322
2019 Q4	$9.14M	Buy	+88,400	New	+$3.57M	1.95%	74
2019 Q2	–	Sell	-30,000	Closed	-$601K	–	670
2019 Q1	$427K	Buy	+30,000	New	+$279K	0.15%	447